title: Denosumab (Prolia): A new option in the treatment of osteoporosis.
authors.affiliation: Trauma Intensive Care Unit, University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, PA, USA.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Belavic
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D000069448:Denosumab; D005260:Female; D006801:Humans; D009722:Nurse Practitioners; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000517:prevention & control*; D053245:RANK Ligand / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D053245:RANK Ligand; D000069448:Denosumab